NK cell triggering by the human costimulatory molecules CD80 and CD86

Julia L. Wilson, Jehad Charo, Alfonso Martín-Fontecha, Paolo Dellabona, Giulia Casorati, Benedict J. Chambers, Rolf Kiessling, Maria Teresa Bejarano, Hans Gustaf Ljunggren

Research output: Contribution to journalArticle

Abstract

NK cell-mediated effector functions are regulated by a delicate balance between positive and negative signals. Receptors transmitting negative signals upon engagement with target cell MHC class I molecules have been characterized in detail in recent years. In contrast, less information is available about receptor-ligand interactions involved in the transmission of positive or 'triggering' signals to NK cells. Recently, it has been described that murine NK cells are triggered by the costimulatory molecules CD80, CD86, and CD40. Using NK cell lines derived from PBMC as effectors, we demonstrate that the human CD80 and CD86 gene products can function as triggering molecules for NK cell-mediated cytotoxicity. Expression of human CD80 or CD86 molecules in murine B16.F1 melanoma cells rendered these significantly more susceptible to lysis by human NK cell lines. Blocking of the transfected gene products with specific mAb reduced lysis levels to that of nontransfected control cell lines. Triggering of human NK cells by CD80 and CD86 appeared to be independent of CD28 and CTLA-4, at least as determined by the reagents used in the present study, because the expression of these molecules could not be detected on the NK cell lines by either flow cytometry or in redirected lysis assays. Thus, human NK cells may use receptors other than CD28 and CTLA-4 in their interactions with CD80 and CD86 molecules. Alternatively, interactions may involve variants of CD28 (and possibly CTLA- 4) that are not recognized by certain anti-CD28 mAb.

Original languageEnglish
Pages (from-to)4207-4212
Number of pages6
JournalJournal of Immunology
Volume163
Issue number8
Publication statusPublished - 1999

Fingerprint

Natural Killer Cells
Cell Line
Genes
Melanoma
Flow Cytometry
Ligands

ASJC Scopus subject areas

  • Immunology

Cite this

Wilson, J. L., Charo, J., Martín-Fontecha, A., Dellabona, P., Casorati, G., Chambers, B. J., ... Ljunggren, H. G. (1999). NK cell triggering by the human costimulatory molecules CD80 and CD86. Journal of Immunology, 163(8), 4207-4212.

NK cell triggering by the human costimulatory molecules CD80 and CD86. / Wilson, Julia L.; Charo, Jehad; Martín-Fontecha, Alfonso; Dellabona, Paolo; Casorati, Giulia; Chambers, Benedict J.; Kiessling, Rolf; Bejarano, Maria Teresa; Ljunggren, Hans Gustaf.

In: Journal of Immunology, Vol. 163, No. 8, 1999, p. 4207-4212.

Research output: Contribution to journalArticle

Wilson, JL, Charo, J, Martín-Fontecha, A, Dellabona, P, Casorati, G, Chambers, BJ, Kiessling, R, Bejarano, MT & Ljunggren, HG 1999, 'NK cell triggering by the human costimulatory molecules CD80 and CD86', Journal of Immunology, vol. 163, no. 8, pp. 4207-4212.
Wilson JL, Charo J, Martín-Fontecha A, Dellabona P, Casorati G, Chambers BJ et al. NK cell triggering by the human costimulatory molecules CD80 and CD86. Journal of Immunology. 1999;163(8):4207-4212.
Wilson, Julia L. ; Charo, Jehad ; Martín-Fontecha, Alfonso ; Dellabona, Paolo ; Casorati, Giulia ; Chambers, Benedict J. ; Kiessling, Rolf ; Bejarano, Maria Teresa ; Ljunggren, Hans Gustaf. / NK cell triggering by the human costimulatory molecules CD80 and CD86. In: Journal of Immunology. 1999 ; Vol. 163, No. 8. pp. 4207-4212.
@article{7f5918e3ce904ba9902c62e33b7622a2,
title = "NK cell triggering by the human costimulatory molecules CD80 and CD86",
abstract = "NK cell-mediated effector functions are regulated by a delicate balance between positive and negative signals. Receptors transmitting negative signals upon engagement with target cell MHC class I molecules have been characterized in detail in recent years. In contrast, less information is available about receptor-ligand interactions involved in the transmission of positive or 'triggering' signals to NK cells. Recently, it has been described that murine NK cells are triggered by the costimulatory molecules CD80, CD86, and CD40. Using NK cell lines derived from PBMC as effectors, we demonstrate that the human CD80 and CD86 gene products can function as triggering molecules for NK cell-mediated cytotoxicity. Expression of human CD80 or CD86 molecules in murine B16.F1 melanoma cells rendered these significantly more susceptible to lysis by human NK cell lines. Blocking of the transfected gene products with specific mAb reduced lysis levels to that of nontransfected control cell lines. Triggering of human NK cells by CD80 and CD86 appeared to be independent of CD28 and CTLA-4, at least as determined by the reagents used in the present study, because the expression of these molecules could not be detected on the NK cell lines by either flow cytometry or in redirected lysis assays. Thus, human NK cells may use receptors other than CD28 and CTLA-4 in their interactions with CD80 and CD86 molecules. Alternatively, interactions may involve variants of CD28 (and possibly CTLA- 4) that are not recognized by certain anti-CD28 mAb.",
author = "Wilson, {Julia L.} and Jehad Charo and Alfonso Mart{\'i}n-Fontecha and Paolo Dellabona and Giulia Casorati and Chambers, {Benedict J.} and Rolf Kiessling and Bejarano, {Maria Teresa} and Ljunggren, {Hans Gustaf}",
year = "1999",
language = "English",
volume = "163",
pages = "4207--4212",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "8",

}

TY - JOUR

T1 - NK cell triggering by the human costimulatory molecules CD80 and CD86

AU - Wilson, Julia L.

AU - Charo, Jehad

AU - Martín-Fontecha, Alfonso

AU - Dellabona, Paolo

AU - Casorati, Giulia

AU - Chambers, Benedict J.

AU - Kiessling, Rolf

AU - Bejarano, Maria Teresa

AU - Ljunggren, Hans Gustaf

PY - 1999

Y1 - 1999

N2 - NK cell-mediated effector functions are regulated by a delicate balance between positive and negative signals. Receptors transmitting negative signals upon engagement with target cell MHC class I molecules have been characterized in detail in recent years. In contrast, less information is available about receptor-ligand interactions involved in the transmission of positive or 'triggering' signals to NK cells. Recently, it has been described that murine NK cells are triggered by the costimulatory molecules CD80, CD86, and CD40. Using NK cell lines derived from PBMC as effectors, we demonstrate that the human CD80 and CD86 gene products can function as triggering molecules for NK cell-mediated cytotoxicity. Expression of human CD80 or CD86 molecules in murine B16.F1 melanoma cells rendered these significantly more susceptible to lysis by human NK cell lines. Blocking of the transfected gene products with specific mAb reduced lysis levels to that of nontransfected control cell lines. Triggering of human NK cells by CD80 and CD86 appeared to be independent of CD28 and CTLA-4, at least as determined by the reagents used in the present study, because the expression of these molecules could not be detected on the NK cell lines by either flow cytometry or in redirected lysis assays. Thus, human NK cells may use receptors other than CD28 and CTLA-4 in their interactions with CD80 and CD86 molecules. Alternatively, interactions may involve variants of CD28 (and possibly CTLA- 4) that are not recognized by certain anti-CD28 mAb.

AB - NK cell-mediated effector functions are regulated by a delicate balance between positive and negative signals. Receptors transmitting negative signals upon engagement with target cell MHC class I molecules have been characterized in detail in recent years. In contrast, less information is available about receptor-ligand interactions involved in the transmission of positive or 'triggering' signals to NK cells. Recently, it has been described that murine NK cells are triggered by the costimulatory molecules CD80, CD86, and CD40. Using NK cell lines derived from PBMC as effectors, we demonstrate that the human CD80 and CD86 gene products can function as triggering molecules for NK cell-mediated cytotoxicity. Expression of human CD80 or CD86 molecules in murine B16.F1 melanoma cells rendered these significantly more susceptible to lysis by human NK cell lines. Blocking of the transfected gene products with specific mAb reduced lysis levels to that of nontransfected control cell lines. Triggering of human NK cells by CD80 and CD86 appeared to be independent of CD28 and CTLA-4, at least as determined by the reagents used in the present study, because the expression of these molecules could not be detected on the NK cell lines by either flow cytometry or in redirected lysis assays. Thus, human NK cells may use receptors other than CD28 and CTLA-4 in their interactions with CD80 and CD86 molecules. Alternatively, interactions may involve variants of CD28 (and possibly CTLA- 4) that are not recognized by certain anti-CD28 mAb.

UR - http://www.scopus.com/inward/record.url?scp=0032845222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032845222&partnerID=8YFLogxK

M3 - Article

C2 - 10510357

AN - SCOPUS:0032845222

VL - 163

SP - 4207

EP - 4212

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 8

ER -